CLX vs EL
Clorox and Estée Lauder Companies (The), both Consumer Defensive
Estée Lauder Companies (The) is the larger company at $31B against $12B. Over the past year EL returned +18% against -13% for CLX. Ryufin's sector-relative Smart Score puts EL ahead, 9/10 against 6/10.
| Figure | CLX | EL |
|---|---|---|
| Last close | $104 | $105 |
| Market cap | $12B | $31B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 16.9 | n/a |
| Dividend yield | 4.7% | 1.6% |
| 1-year return | -13% | +18% |
| 5-year return | -32% | -66% |
| Ryufin Smart Scoresector-relative, 1–10 | 6/10 | 9/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Clorox
Revenue of $1.7B in Q3 2026, net income $187M. Its largest reported line is Health And Wellness, 38% of the disclosed total.
Estée Lauder Companies (The)
Revenue of $3.7B in Q3 2026, net income $89M.
Open these two in the interactive comparison to add more names, change the period or read the correlation.